ALRM's slow growth & high costs weigh on its 3.4x P/S. LZ's 177% EPS growth & 14.9% FCF margin shine at 10.7x EV/EBITDA.
TGNA revenue drops 2.5%, NMRK sales flat, WT revenue up 18.6%. Traders eye P/E ratios.
NXT surges 22% on strong backlog & cash flow, while EGHT (+17.8%) faces weak growth & NNBR (-5%) struggles with declining sales.
Stryker (SYK) shines with 10.2% growth & 13.3% EPS growth, trading at 27.8x P/E. LSCC & PVH lag.
NPO's 29x P/E signals risk despite flat sales; TRN's 6.2x EV/EBITDA reflects sales decline; CPNG's 29.6x EV/EBITDA shows growth.
Anthropic's $1.5B AI settlement: $3k/book payout faces hurdles. Judge demands clarity on distribution, authors await net sum.
CFLT surges 17.5% on billings growth, TBBK up 13.1% on net interest income. LEG dips 10.6% on stagnant sales & falling EPS.
Sponsored
Must Read